The cholesterol, high‐density lipoprotein, and glucose index and its derivatives related to obesity and inflammation as novel metabolic markers for predicting new‐onset cardiovascular‐liver‐metabolic multimorbidity: A prospective cohort study
ABSTRACT Background Cardiovascular‐liver‐metabolic multimorbidity (CLMM), defined as the co‐occurrence of at least two of cardiovascular disease, type 2 diabetes, and metabolic dysfunction‐associated steatotic liver disease, is an increasing health burden. We evaluated the cholesterol, high‐density lipoprotein, and glu...